Evidence map›Paper›PMID 28647347›Full record

ArticleThe Journal of investigative dermatology2017

Differential Activation of Human Keratinocytes by Leishmania Species Causing Localized or Disseminated Disease.

Breanna M Scorza, Mark A Wacker, Kelly Messingham, Peter Kim, Aloysius Klingelhutz, Janet Fairley, Mary E Wilson

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of investigative dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Oxidative Stress and Survival ofExpert reviews in molecular medicine · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. The journal of venomous animals and toxins including tropical diseases · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Breanna M ScorzaUniversity of Iowa, Interdisciplinary Graduate Program in Immunology, Iowa City, Iowa, USA.
Mark A WackerUniversity of Iowa, Department of Internal Medicine, Iowa City, Iowa, USA.
Kelly MessinghamUniversity of Iowa, Department of Dermatology, Iowa City, Iowa, USA.
Peter KimUniversity of Iowa, Carver College of Medicine, Iowa City, Iowa, USA.
Aloysius KlingelhutzUniversity of Iowa, Department of Microbiology, Iowa City, Iowa, USA.
Janet FairleyUniversity of Iowa, Department of Dermatology, Iowa City, Iowa, USA; Veterans' Affairs Medical Center, Iowa City, Iowa, USA.
Mary E WilsonUniversity of Iowa, Interdisciplinary Graduate Program in Immunology, Iowa City, Iowa, USA; University of Iowa, Department of Internal Medicine, Iowa City, Iowa, USA; University of Iowa, Department of Microbiology, Iowa City, Iowa, USA; Veterans' Affairs Medical Center, Iowa City, Iowa, USA. Electronic address: mary-wilson@uiowa.edu.
University of Iowa · US

Funding

TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
Protective Immunity to Leishmania chagasiR01AI045540 · NIAID · UNIVERSITY OF IOWA · PI WILSON, MARY E · 2001 to 2011
$3.1M
Genetic Risk Factors for Visceral LeishmaniasisR01AI076233 · NIAID · UNIVERSITY OF IOWA · PI BLACKWELL, JENEFER MARY, WILSON, MARY E · 2009 to 2013
$1.6M
The Role of Exosomes in the Pathogenesis of LeishmaniasisI01BX000536 · VA · IOWA CITY VA MEDICAL CENTER · PI WILSON, MARY E · 2009 to 2023
–
Innate inflammatory cells in leishmaniasisI01BX001983 · VA · IOWA CITY VA MEDICAL CENTER · PI WILSON, MARY E · 2014 to 2022
–
BLRD VA I01 BX000536BLRD VA I01 BX001983NIAID NIH HHS R01 AI045540NIAID NIH HHS R01 AI076233NIAID NIH HHS T32 AI007511
6 · The paper itself

Abstract

All Leishmania species parasites are introduced into mammalian skin through a sand fly bite, but different species cause distinct clinical outcomes. Mouse studies suggest that early responses are critical determinants of subsequent adaptive immunity in leishmaniasis, yet few studies address the role of keratinocytes, the most abundant cell in the epidermis. We hypothesized that Leishmania infection causes keratinocytes to produce immunomodulatory factors that influence the outcome of infection. Incubation of primary or immortalized human keratinocytes with Leishmania infantum or Leishmania major, which cause visceral or cutaneous leishmaniasis, respectively, elicited dramatically different responses. Keratinocytes incubated with L. infantum significantly increased expression of proinflammatory genes for IL-6, IL-8, tumor necrosis factor, and IL-1B, whereas keratinocytes exposed to several L. major isolates did not. Furthermore, keratinocyte-monocyte co-incubation studies across a 4 µM semipermeable membrane suggested that L. infantum-exposed keratinocytes release soluble factors that enhance monocyte control of intracellular L. infantum replication (P < 0.01). L. major-exposed keratinocytes had no comparable effect. These data suggest that L. infantum and L. major differentially activate keratinocytes to release factors that limit infection in monocytes. We propose that keratinocytes initiate or withhold a proinflammatory response at the site of infection, generating a microenvironment uniquely tailored to each Leishmania species that may affect the course of disease.

Indexed as

AnimalsCells, CulturedCytokinesDisease ProgressionGene Expression RegulationHumansKeratinocytesLeishmaniaLeishmaniasis, CutaneousRNA, ProtozoanCytokinesRNA, Protozoan

Identifiers

PMID28647347
PMCPMC5786447
OpenAlexW2713959743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.